ArticleJournal of the Canadian Association of Gastroenterology2026
Effectiveness of vedolizumab to reduce bowel urgency in a Canadian real-world inflammatory bowel disease cohort.
Parul Tandon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.